Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2012 Nov;10(4):230-5.
doi: 10.3121/cmr.2012.1049. Epub 2012 May 25.

Brain abscesses complicating acute pneumococcal meningitis during etanercept therapy

Affiliations
Case Reports

Brain abscesses complicating acute pneumococcal meningitis during etanercept therapy

Yusuf Kasirye et al. Clin Med Res. 2012 Nov.

Abstract

Brain abscess formation as a sequelae of community-acquired pneumococcal meningitis is extremely rare, accounting for less than 1% of all meningitis complications. Although metastatic seeding from a distal peripheral septic focus has been observed, this phenomenon most commonly occurs in the context of ear, nose and throat infections, post-cranial neurosurgical procedures, traumatic open cranial injury, or immunosuppression. We present the case of a man, 61 years old, on etanercept therapy for ankylosing spondylitis who developed multiple brain abscesses as a complication of pneumococcal meningitis. We believe that the predisposition to this extremely rare complication of a particularly aggressive pneumococcal meningitis was most likely due to the underlying immunosuppression resulting from etanercept therapy. As far as we know, this case is the first report linking multiple brain abscess formation in a patient with community-acquired pneumococcal meningitis with etanercept therapy.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Computed tomography of the head without contrast done on day 2 of admission showing a focal hyper-dense image in the right frontal lobe parenchyma, consistent with intracerebral hemorrhage (see arrow) with surrounding edema.
Figure 2
Figure 2
T2-weighted contrast-enhanced magnetic resonance imaging study showing increased signal intensity in the right frontal lobe and in the anterior periventricular areas consistent with cerebritis and ventriculitis (see arrows). Minimal mass effect is also noted.
Figure 3
Figure 3
Contrast-enhanced computed tomography of the head done 14 days after admission showing 3 ring-enhancing lesions (see arrows) in the frontal lobe with low-density edema surrounding them.
Figure 4
Figure 4
Contrast-enhanced computed tomography of the head done after 6 weeks of antibiotic treatment. The ring-enhancing lesions evident on figure 3 have practically disappeared and now are seen as small focal areas of enhancement (see arrow). Associated low-density edema has also decreased.

Similar articles

Cited by

References

    1. Bazzoni F, Beutler B. The tumor necrosis factor ligand and receptor families. N Engl J Med 1996;334:1717-1725 - PubMed
    1. Tobinick EL, Gross H. Rapid improvement in verbal fluency and aphasia following perispinal etanercept in Alzheimer's disease. BMC Neurol 2008;8:27. - PMC - PubMed
    1. Tobinick E. Tumour necrosis factor modulation for treatment of Alzheimer's disease: rationale and current evidence. CNS Drugs 2009;23:713–725 - PubMed
    1. Tak PP, Kalden JR. Advances in rheumatology: new targeted therapeutics. Arthritis Res Ther 2011;13 Suppl 1:S5. - PMC - PubMed
    1. Bresnihan B, Cunnane G. Infection complications associated with the use of biologic agents. Rheum Dis Clin North Am 2003;29:185-202 - PubMed

Publication types

MeSH terms

Substances